A Randomized Study of Interferon α-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma

BACKGROUND. Patients with lymphoma who have experienced a first relapse or progression and have disease deemed sensitive to salvage chemotherapy nevertheless have a high likelihood of having a second relapse. To decrease the likelihood of a second relapse after high-dose therapy (HDT) and autologous...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bosly, André, Grigg, Andrew, Holte, Harald, Gisselbrecht, Christian, Radford, John, Rossi, Andrea, Lopez-Guillermo, Armando, Trneny, Marek, Sebban, Catherine, Hagberg, Hans, Leal da Costa, Fernando, Colombat, Philippe, Bron, Dominique, Coiffier, Bertrand
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2013
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825302/
https://ncbi.nlm.nih.gov/pubmed/24105750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0223
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires